In the evolving TME with both tumor and stromal cells (fibroblast, inflammatory and endothelial cells) that express increasing levels of active MMPs, first the MMP-independent functions and eventually the MMP-inhibitory activity of TIMP2 is overwhelmed. Here, TIMP2 is linked to neoplasm.